Dr. Kimball is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
375 Longwood Ave
Boston, MA 02215Phone+1 617-632-7443
Summary
- Dr. Alexa B. Kimball is a dermatologist in Boston, MA and is affiliated with Beth Israel Deaconess Medical Center. She received her medical degree from Yale University School of Medicine and has been in practice 23 years. She is experienced in general dermatology, psoriasis, hidradenitis suppurativa, clinical research, and complex medical dermatology.
Education & Training
National Institutes of Health Clinical CenterResidency, Dermatology, 1998 - 2000
Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 1995 - 1998
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1994 - 1995
Yale School of MedicineClass of 1994
Publications & Presentations
PubMed
- 46 citationsChallenges facing academic dermatology: survey data on the faculty workforce.Jack S. Resneck, Emily P. Tierney, Alexa B. Kimball
Journal of the American Academy of Dermatology. 2006-02-01 - 16 citationsMeta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne.Elizabeth M. Seidler, Alexa B. Kimball
Journal of the American Academy of Dermatology. 2011-10-01 - 43 citationsMeta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acneElizabeth M. Seidler, Alexa B. Kimball
Journal of the American Academy of Dermatology. 2010-07-01
Authored Content
- Is There a Prescription for Mandatory Physician Training?January 2024
- Healthcare Provider: Telehealth Visits Should Be ProtectedMay 2022
- Hidradenitis Suppurativa: Much Progress, but Skip the SmoothiesMay 2021
- Treat-to-Target Is Popular, but Not Without Its CriticsMarch 2019
- Reliability of the Hidradenitis Suppurativa Clinical Response (HiSCR) in the Assessment of Patients with Hidradenitis SuppurativaJune 2018
- Join now to see all
Press Mentions
Reviewers' List December 2019August 23rd, 2019
Pain Control Benefits HS PatientsJuly 11th, 2017- Ethnic Variations in AgingJune 2nd, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
